The present invention provides a composition of a mixture comprising Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma et Radix Notopterygii and Radix Angelicae Pubescentis, and an herbal extract composition of a mixture comprising Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma et Radix Notopterygii and Radix Angelicae Pubescentis. A method for preparing the herbal extract composition and a product by the method thereof is further provided by the present invention. The herbal extract composition is useful for alleviating pain and treating diseases such as rheumatoid arthritis (RA) or osteoarthritis (OA).

The present invention provides a composition of a mixture comprising Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma et Radix Notopterygii and Radix Angelicae Pubescentis, and an herbal extract composition of a mixture comprising Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma et Radix Notopterygii and Radix Angelicae Pubescentis. A method for preparing the herbal extract composition and a product by the method thereof is further provided by the present invention. The herbal extract composition is useful for alleviating pain and treating diseases such as rheumatoid arthritis (RA) or osteoarthritis (OA).

The present invention comprises an agent exhibiting an antiarrhythmic effect, extracted from plants of genus Aconitum family Ranunculaceae, containing the alkaloids lappaconitine, N-acetylsepaconitine, 1-desmethyllappaconitine, ranaconitine, N-deacetyllappaconitine, isolappaconitine, 9-deoxy-lappaconitine or pharmaceutically acceptable salts thereof. The agent contains alkaloids in the form of hydrobromide salts of lappaconitine, N-acetylsepaconitine, 1-desmethyllappaconitine, ranaconitine, N-deacetyllappaconitine, isolappaconitine, and 9-deoxy-lappaconitine. In specific implementations, the agent may be extracted from the rhizomes and roots of the plant Aconitum septentrionale Koelle, from the rhizomes and roots of the plant Aconitum leucostomum, or from the herb of the plant Aconitum leucostomum, all of the family Ranunculaceae. A pharmaceutical composition for oral administration comprises the agent in an effective quantity and a pharmaceutically acceptable carrier. Preferably, the pharmaceutically acceptable carrier contains starch, sucrose, calcium stearate, and croscarmellose sodium. The present invention provides a more effective and safe cardioprotective agent for the prevention and treatment of arrhythmia.

The present invention comprises an agent exhibiting an antiarrhythmic effect, extracted from plants of genus Aconitum family Ranunculaceae, containing the alkaloids lappaconitine, N-acetylsepaconitine, 1-desmethyllappaconitine, ranaconitine, N-deacetyllappaconitine, isolappaconitine, 9-deoxy-lappaconitine or pharmaceutically acceptable salts thereof. The agent contains alkaloids in the form of hydrobromide salts of lappaconitine, N-acetylsepaconitine, 1-desmethyllappaconitine, ranaconitine, N-deacetyllappaconitine, isolappaconitine, and 9-deoxy-lappaconitine. In specific implementations, the agent may be extracted from the rhizomes and roots of the plant Aconitum septentrionale Koelle, from the rhizomes and roots of the plant Aconitum leucostomum, or from the herb of the plant Aconitum leucostomum, all of the family Ranunculaceae. A pharmaceutical composition for oral administration comprises the agent in an effective quantity and a pharmaceutically acceptable carrier. Preferably, the pharmaceutically acceptable carrier contains starch, sucrose, calcium stearate, and croscarmellose sodium. The present invention provides a more effective and safe cardioprotective agent for the prevention and treatment of arrhythmia.

An herbal formula used for preparing a pharmaceutical composition for preventing and treating metabolic syndrome is provided. The herbal formula includes Rehmanniae radix preparata, Cornus officinalis, Dioscorea polystachya, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Aconitum carmichaeli, and Cinnamomum cassia.

An herbal formula used for preparing a pharmaceutical composition for preventing and treating metabolic syndrome is provided. The herbal formula includes Rehmanniae radix preparata, Cornus officinalis, Dioscorea polystachya, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Aconitum carmichaeli, and Cinnamomum cassia.

An herbal formula used for preparing a pharmaceutical composition for preventing and treating metabolic syndrome is provided. The herbal formula includes Rehmanniae radix preparata, Cornus officinalis, Dioscorea polystachya, Alisma plantago-aquatica, Paeonia suffruticosa, Poria cocos, Aconitum carmichaeli, and Cinnamomum cassia.

The present invention discloses a composition for preparing a pain relieving drug, which includes poplar bark, Ligusticum wallichii, curcumin, ambergris, processed Radix Aconiti Lateralis, ray cartilage extract, wild ginseng, fructus psoraleae, garden balsam stem, pratt mountainash root-bark, annona muricata, Arisaema heterophyllum Blume, resina draconis, frankincense, myrrh, Brazilian sapodilla and camphor. The composition can be added with an appropriate auxiliary material to be made into dosage forms suitable for oral administration or external use, such as oral liquid, a patch, a liniment, a sustained-release agent and the like.

The present invention discloses a composition for preparing a pain relieving drug, which includes poplar bark, Ligusticum wallichii, curcumin, ambergris, processed Radix Aconiti Lateralis, ray cartilage extract, wild ginseng, fructus psoraleae, garden balsam stem, pratt mountainash root-bark, annona muricata, Arisaema heterophyllum Blume, resina draconis, frankincense, myrrh, Brazilian sapodilla and camphor. The composition can be added with an appropriate auxiliary material to be made into dosage forms suitable for oral administration or external use, such as oral liquid, a patch, a liniment, a sustained-release agent and the like.

The present invention discloses a composition for preparing a pain relieving drug, which includes poplar bark, Ligusticum wallichii, curcumin, ambergris, processed Radix Aconiti Lateralis, ray cartilage extract, wild ginseng, fructus psoraleae, garden balsam stem, pratt mountainash root-bark, annona muricata, Arisaema heterophyllum Blume, resina draconis, frankincense, myrrh, Brazilian sapodilla and camphor. The composition can be added with an appropriate auxiliary material to be made into dosage forms suitable for oral administration or external use, such as oral liquid, a patch, a liniment, a sustained-release agent and the like.